Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 11, 2019
[Level of Regulatory B Cells in Patients with Immune Thrombocytopenia and Its Clinical Significance]Shi-Rong Zhu, Hai-Yan Chen, Ming-Jing Wang, et al.
Cost Effectiveness and Resource Allocation : C/E|April 16, 2019
Effect of inappropriate admissions on hospitalization performance in county hospitals: a cross-sectional study in rural ChinaJing-Jing Chang, Ying-Chun Chen, Hong-Xia Gao, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|April 9, 2022
[Analysis of DNA Methylation Gene Mutations and Clinical Features in Patients with Myeloproliferative Neoplasm]Zi-Qing Wang, Yu-Jin Li, De-Hao Wang, et al.
Plos One|October 22, 2015
Performance Assessment of Internal Quality Control (IQC) Products in Blood Transfusion Compatibility Testing in ChinaGui-Ping Xu, Li-Fang Wu, Jing-Jing Li, et al.
International Journal of Oncology|October 16, 2013
Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell linesHidetomo Kikuchi, Bo Yuan, Yoshio Nishimura, et al.
Chinese Journal of Integrative Medicine|December 19, 2019
Arsenic-Containing Qinghuang Powder () is an Alternative Treatment for Elderly Acute Myeloid Leukemia Patients Refusing Low-Intensity ChemotherapyTeng Fan, Ri-Cheng Quan, Wei-Yi Liu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 9, 2023
[Possible Risk Factors for Bone Marrow Fibroplasia in Patients with Polycythemia Vera]De-Hao Wang, Pei Zhao, Zi-Qing Wang, et al.
Chinese Journal of Integrative Medicine|July 2, 2009
Effect and prognostic analysis of treatment for acute myeloid leukemia using Chinese drugs combined with chemotherapyXiao-mei Hu, Feng Liu, Chun-mei Zheng, et al.
Scientific Reports|July 15, 2017
Twins methods quantitatively explore the genetic impact on children and adolescents brain gray matter volumeXiao-Lu Chen, Xiao-Wei Zhang, Xiao Hou, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 22, 2024
[Comparison of Clinical Characteristics of <i>JAK2, CALR</i> and Tri-Negative Driving Mutant Type in Patients with Essential Thrombocythemia]Yu-Meng Li, Er-Peng Yang, Zi-Qing Wang, et al.
Pageof 8